- Filed
- Jul 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Jul 7, 2025 | 3.63M sh |
| Current Liabilities | Q1 2026 · Apr 30, 2025 | $0 |
| Current Liabilities | Q1 2026 · Jan 31, 2025 | $12.48K |
| Total Liabilities | Q1 2026 · Apr 30, 2025 | $0 |
| Total Liabilities | Q1 2026 · Jan 31, 2025 | $100.37K |
| Current Assets | Q1 2026 · Apr 30, 2025 | $54 |
| Current Assets | Q1 2026 · Jan 31, 2025 | $89 |
| Total Assets | Q1 2026 · Apr 30, 2025 | $30.46K |
| Total Assets | Q1 2026 · Jan 31, 2025 | $32.54K |
| Operating Income | Q1 2026 · Apr 30, 2025 | −$16.45K |
| Operating Income | Q1 2026 · Apr 30, 2024 | −$19.62K |
| Net Income | Q1 2026 · Jan 31, 2025 | −$27.57K |
| Net Income | Q1 2026 · Apr 30, 2024 | −$19.62K |
| Net Income | Q1 2026 · Jan 31, 2024 | −$40.25K |
| Net Income | Q1 2026 · Jan 31, 2023 | −$22.19K |
| Net Income restated | Q1 2026 · Jan 31, 2022 | −$731 |
| Shares Diluted restated | Q1 2026 · Apr 30, 2024 | 3.57M sh |
| Operating Cash Flow | Q1 2026 · Apr 30, 2024 | −$21.67K |
| Cash And Equivalents | Q1 2026 · Apr 30, 2024 | $106 |
| Cash And Equivalents | Q1 2026 · Jan 31, 2024 | $4.45K |
| Eps Diluted | Q1 2026 · Apr 30, 2024 | $0.00 |
| Eps Basic | Q1 2026 · Apr 30, 2024 | $0.00 |
| Sga Expense | Q1 2026 · Apr 30, 2024 | $19.62K |
| Revenue | Q1 2026 · Apr 30, 2024 | $0 |
| Stockholders Equity | Q1 2026 · Jan 31, 2024 | −$40.26K |
| Stockholders Equity | Q1 2026 · Jan 31, 2023 | −$1.32K |
| Stockholders Equity | Q1 2026 · Jan 31, 2022 | −$481 |
| Stockholders Equity | Q1 2026 · Jan 9, 2022 | $0 |